25 May – 31 May 2026

Mandates and market pressure converged this week: the federal electronic assignment rule for bulk billing, Epic's fraught Hunter New England go‑live and ANDHealth's survey together make upgrading consent capture, security and capital plans unavoidable for Australian health tech vendors.

First, the compliance cliff is real. The Health Insurance Legislation Amendment Act 2024 takes effect on 1 July 2026 and will require roughly 7,000 practices to capture digital consent for bulk‑billing and keep records for two years. Combined with RACGP calls for a linked primary care dataset and explicit AI governance, procurement teams will start asking for audit trails, consent workflows and real‑time integration as contract preconditions. Vendors that already embed consent capture and interoperable APIs gain a procurement advantage. Legacy and small practice systems that cannot be upgraded quickly will face either replacement costs or exclusion from new funding and accreditation pathways.

Second, funding and consolidation are reshaping who can scale. ANDHealth’s industry survey shows 92 per cent of digital health SMEs plan to seek growth capital in the next 12 months and access to capital ranks among the top challenges. At the same time, policy moves on capital gains tax and a proposed minimum tax on discretionary trusts will lower the value of equity incentives and increase exit pressure. Those forces are already pushing vendors offshore or into M&A. Evidence this week includes Alcidion’s seven‑year Miya Precision deal with University Hospitals Sussex and Jardines’ AUD 3.4 billion purchase of I‑MED, including Harrison.ai interests. The advantage is shifting to firms with scale, export traction or deep pockets, while early stage players without pilot evidence will struggle to convert interest into durable funding.

Third, AI and security are accelerating from theory to procurement criteria, but serious constraints remain. Regulators are treating auditable AI documentation as a billing and safety issue, and the NZ Manage My Health breach that hit about 100,000 patients raised the cost of vendor risk. At the same time, I‑MED’s sale brings AI radiology assets under a single corporate owner, forcing competitors to choose rapid integration, partnership or exit. Momentum for regulated AI and hardened cloud security is building, and buyers will pay premiums for demonstrable governance, not vague assurances.

Contrarian read. The week also underlined that technology is necessary, but not sufficient. Epic’s Hunter New England implementation showed how workforce fatigue and frontline resistance can delay value realisation and inflate support costs. Implementation failure modes include degraded data quality, billing errors from poorly audited AI notes, and patient access gaps when consent workflows are clunky. For executives betting on rapid AI or EPR rollouts, the constraint is human capacity and practical governance, not capability alone.

• Federal government enacted the Health Insurance Legislation Amendment Act 2024 taking effect 1 July 2026 — forces about 7,000 practices to implement digital bulk‑billing consent capture and two‑year record retention, obliging EMR and practice management vendors to add audit trails.
• NSW Health completed the Epic go‑live at Hunter New England after earlier staff pushback — demonstrates that large EPR rollouts still create frontline workforce strain and extend vendor support windows, raising hospitals’ implementation budgets.
• ANDHealth published its 2026 Industry Sentiment Survey showing 92 per cent of SMEs will seek growth capital within 12 months — intensifies pressure on founders to prove export traction or clinical outcomes before they can access scale funding.
• Federal budget CGT and discretionary trust proposals advanced policy change — replacing the 50 per cent CGT discount and imposing a 30 per cent minimum tax on gains from 1 July 2027 will reduce equity upside and accelerate exits or offshoring of talent.
• Jardines acquired I‑MED Radiology Network for AUD 3.4 billion including Harrison.ai stakes — centralises AI radiology capability under a major buyer and forces smaller imaging operators to partner, sell or accelerate AI deployments.
• Alcidion secured a seven‑year Miya Precision contract with University Hospitals Sussex worth about $35 million to $49 million — validates demand for modular cloud EPRs and rewards vendors with scalable architectures.
• RACGP released its 2026–30 Advocacy Plan calling for a national linked primary care dataset and an AI governance framework — requires EMR vendors and PHNs to prepare for near real‑time data sharing and stricter audit standards.
• The NZ Manage My Health breach affected almost 100,000 patients — increases procurement scrutiny and makes independent security certification and vendor risk transfer standard terms in contracts.
• AHPRA issued telehealth guidance during the petrol disruption — pushes regional clinics to buy resilient remote‑care tooling and makes continuity planning a procurement requirement.
• ANDHealth+ invested up to AUD 9 million across five ventures at Digital Health Festival DHF26 — signals that selective scaling capital is available for clinically validated solutions, making clinical trial and deployment metrics the currency for follow‑on funding.